Results 21 to 30 of about 415,778 (252)

ESM1 Interacts with c-Met to Promote Gastric Cancer Peritoneal Metastasis by Inducing Angiogenesis

open access: yes, 2023
The peritoneum is the most common metastatic site of advanced gastric cancer and is associated with extremely poor prognosis. Endothelial-specific molecule 1 (ESM1) was found to be significantly associated with gastric cancer peritoneal metastasis (GCPM);
Tao Chen   +9 more
core   +1 more source

Establishment and verification of prediction model of occult peritoneal metastasis in advanced gastric cancer

open access: yesWorld Journal of Surgical Oncology, 2023
Background To investigate the risk factors associated with the development of occult peritoneal metastasis in advanced gastric cancer, and establish and externally validate a nomogram for predicting the occurrence of occult peritoneal metastasis in ...
Hengfei Gao   +7 more
doaj   +1 more source

CXCL8 and the peritoneal metastasis of ovarian and gastric cancer

open access: yesFrontiers in Immunology, 2023
CXCL8 is the most representative chemokine produced autocrine or paracrine by tumor cells, endothelial cells and lymphocytes. It can play a key role in normal tissues and tumors by activating PI3K-Akt, PLC, JAK-STAT, and other signaling pathways after ...
Xuanrong Fu   +3 more
doaj   +1 more source

HAPLN1 potentiates peritoneal metastasis in pancreatic cancer [PDF]

open access: yes, 2023
The presence of peritoneal metastasis in pancreatic cancers is associated with poor prognosis. Here the authors show that hyaluronan and proteoglycan link protein-1 (HAPLN1) promotes tumour cell plasticity and pro-tumoral immune microenvironment to ...
Wiedmann, Lena   +41 more
core   +1 more source

mPEG-PDLLA Micelles Potentiate Docetaxel for Intraperitoneal Chemotherapy in Ovarian Cancer Peritoneal Metastasis

open access: yesFrontiers in Pharmacology, 2022
Ovarian cancer is the second most common cause of gynecological cancer death in women. It is usually diagnosed late and accompanied by peritoneal metastasis.
Yumei Zhang   +8 more
doaj   +1 more source

Peritoneal Metastases: Evolution from a Dark Horizon to an Encouraging Present and a Promising Future [PDF]

open access: yes, 2023
Peritoneal metastasis (PM) is the primary pattern of metastasis for primary tumours of the appendix, ovary, and peritoneal mesothelioma [...
Alberto San-Juan   +7 more
core   +1 more source

Prevalence, risk factors, and prognosis of peritoneal metastasis from breast cancer [PDF]

open access: yes, 2015
Peritoneal metastasis from breast cancer is a serious and deadly condition only limited considered in the literature. Our aim was to study prevalence, risk factors, and prognosis of breast cancer peritoneal metastasis.
Uzzau A.   +8 more
core   +2 more sources

PN3b as an independent risk factor for poor prognosis and peritoneal recurrence in Borrmann type IV gastric cancer: A retrospective cohort study

open access: yesFrontiers in Surgery, 2022
BackgroundThe clinicopathological features and surgical treatment strategies of Borrmann type IV gastric cancer (GC) remain controversial. Peritoneal metastasis is the most common recurrence pattern in patients with Borrmann type IV GC.MethodsAmong 2026 ...
Yiran Chen   +5 more
doaj   +1 more source

MiR-136 inhibits gastric cancer–specific peritoneal metastasis by targeting HOXC10

open access: yesTumor Biology, 2017
Functions of microRNAs have been characterized in the embryologic, physiologic, and oncogenic processes, but the role of microRNAs in mediating tumor-specific organ metastasis was addressed only recently and still absent in gastric cancer peritoneal ...
Jianyong Zheng   +5 more
doaj   +1 more source

Taurolidine reduces the tumor stimulating cytokine interleukin-1beta in patients with resectable gastrointestinal cancer : a multicentre prospective randomized trial [PDF]

open access: yes, 2009
Background The effect of additional treatment strategies with antineoplastic agents on intraperitoneal tumor stimulating interleukin levels are unclear.
Willems Wilhelm   +20 more
core   +1 more source

Home - About - Disclaimer - Privacy